While demonstrating competitive performance within this controlled setting, these promising outcomes highlight the potential of TransNTSeg for accurate NT segmentation. This warrants further validation on multicenter, multi-vendor datasets to establish its generalizability for broad clinical use.
Wang et al. (Wed,) studied this question.